SCHEMBL18945552

SCHEMBL18945552

CN(C)C(=O)c1ncncc1Br

nearest known ligand 0.40

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP1A2 P05177 13/20 0.40
CYP3A4 P08684 12/20 0.40
HSD17B10 Q99714 9/20 0.40
ALDH1A1 P00352 8/20 0.40
CYP2C19 P33261 6/20 0.40
ALOX15 P16050 4/20 0.40
KDM4E B2RXH2 2/20 0.40
HPGD P15428 1/20 0.40
PDE10A Q9Y233 2/20 0.37
TSHR P16473 6/20 0.35
CYP2D6 P10635 6/20 0.35
CLK4 Q9HAZ1 4/20 0.35
HTT P42858 1/20 0.33
SMN1; SMN2 Q16637 1/20 0.33
NTRK1 P04629 1/20 0.33
USP2 O75604 1/20 0.33
TDP1 Q9NUW8 2/20 0.32
GLA P06280 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL14484671 0.83 PDE10A (0.34) CYP1A2CYP3A4HSD17B10ALDH1A1CYP2C19
SCHEMBL629032 0.78 HCAR2 (0.44) CYP3A4HSD17B10ALDH1A1CYP2C19ALOX15
SCHEMBL30978924 0.78 HCAR2 (0.44) CYP3A4HSD17B10ALDH1A1CYP2C19ALOX15
SCHEMBL18930374 0.78 CYP1A2 (0.40) CYP1A2CYP3A4HSD17B10ALDH1A1CYP2C19
SCHEMBL18930376 0.75 CYP1A2 (0.38) CYP1A2CYP3A4HSD17B10ALDH1A1CYP2C19
SCHEMBL23925748 0.75 ADORA3 (0.36) ALDH1A1TSHRSMN1; SMN2NTRK1
SCHEMBL9956039 0.75 NTRK1 (0.33) NTRK1
SCHEMBL630362 0.74 NPSR1 (0.43) CYP1A2ALDH1A1CYP2C19KDM4ETSHR
SCHEMBL15228341 0.74 NTRK1 (0.43) PDE10ANTRK1USP2
SCHEMBL29574660 0.74 NPSR1 (0.43) CYP1A2ALDH1A1CYP2C19KDM4ETSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2017093544-A1 ALKYNYL PHOSPHINE GOLD COMPLEXES FOR TREATING BACTERIAL INFECTIONS AUSPHERIX LIMITED (GB) 2017-06-08 WO disclosed